The Life Science Tools Market is estimated to be valued at US$ 125.19 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The Life Science Tools Market comprises products such as spectrometers and specialized microscopes that are used across a wide range of applications in industries such as biotechnology, pharmaceutical, academic research, agriculture and clinical research. Technological advancements in cellular and molecular biology techniques have increased the demand for advanced tools that can efficiently study biological processes at molecular and cellular levels. Increasing R&D investments in drug discovery and clinical trials are also driving the market growth.
Market Dynamics:
Technological innovations and digital transformation: Continuous innovations in technologies such as proteomics, genetic engineering, and bioprocessing are expanding the capabilities of life science tools. Integration of AI and automation is enabling advanced data analysis and improved efficiency of research processes. Many tools are becoming compact, portable and easier to use which is increasing their adoption.
Growing biotechnology and pharmaceutical industries: Growing demand for healthcare, increasing disease burden and rising focus on drug development are fueling investments in biotechnology and pharmaceutical industries. Expanding clinical trial activities and focus on precision medicine are also driving the need for advanced life science tools in research and development processes.
Segment Analysis
The life science tools market can be segmented based on technology and application. The molecular diagnostics segment dominates the market, accounting for over 30% share in 2022. Molecular diagnosis helps detect diseases at the genetic level which helps health professionals to provide custom treatment. This has increased the adoption of molecular diagnostic tools in the life science industry.
PEST Analysis
Political: Government initiatives to increase funding for R&D in life science tools help market growth. For instance, governments of various countries have increased funding for development of advanced diagnosis and treatment facilities.
Economic: Rising healthcare expenditure and economic growth in emerging markets provide opportunities for life science tools market.
Social: Increasing prevalence of chronic and infectious diseases is a key factor driving demand for tools that help diagnose and treat such conditions.
Technological: Advancements in genomics, proteomics, and molecular diagnostics are prompting development of innovative life science tools. Miniaturization of devices also supports market growth.
Key Takeaways
The Global Life Science Tools Market size was valued at US$ 125.19 Mn in 2023 and is expected to reach US$ 250 Mn by 2030, exhibiting a CAGR of 12% over the forecast period. The growing incidence of target diseases such as cancer and infectious diseases across the world contributes to market growth.
Regionally, North America dominates the life science tools market and is expected to continue its dominance during the forecast period. This is attributed to advanced research infrastructure and availability of skilled professionals in the region.
Key players operating in the life science tools market are Agilent Technologies, Inc., BD, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Danaher, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Shimadzu Corporation, Hitachi, Ltd., Bruker, Oxford Instruments, ZEISS International, Hamilton Company, and Beckman Coulter, Inc. Leading players are focusing on new product launches and strategic collaborations with academia and research institutes to strengthen their market position.
Read More:
https://www.pressreleasebulletin.com/life-science-tools-market-trends-insights-and-growth/
